Article Information
PubMed
Published By
History
- Received March 10, 2005
- Revision received May 6, 2005
- Accepted May 7, 2005
- First published June 8, 2005.
- Version of record published June 8, 2005.
Copyright & Usage
Copyright © 2005 Society for Neuroscience 0270-6474/05/255645-06.00/0
Author Information
- 1Preclinical Pharmacology Section, Behavioral Neuroscience Research Branch and 2Psychobiology Section, Medications Discovery Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Baltimore, Maryland, 21224, and 3Laboratoire de Biologie et Physiologie Cellulaire, Université de Poitiers, 86022, Poitiers, France
Author contributions
Disclosures
- Received March 10, 2005.
- Revision received May 6, 2005.
- Accepted May 7, 2005.
This work was supported by the Intramural Research Program of the National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services. We thank Drs. Daniele Piomelli and Alexandros Makriyannis for helpful suggestions and comments while conducting this research.
Correspondence should be addressed to Dr. Steven R. Goldberg, Preclinical Pharmacology Section, Behavioral Neuroscience Research Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, 5500 Nathan Shock Drive, Baltimore, MD 21224. E-mail: sgoldber{at}intra.nida.nih.gov.
Copyright © 2005 Society for Neuroscience 0270-6474/05/255645-06$15.00/0
